Wall St slips as uncertainty surrounds U.S. election
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
The Nobel Prize in Physiology or Medicine has been awarded to scientists Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA, tiny genetic elements that regulate gene activity at the cellular level. This pivotal finding holds significant promise for developing innovative cancer therapies.
The announcement, made on Monday, marks the start of the 2024 Nobel Prize season, which celebrates extraordinary achievements across science, economics, literature, and peace. The Nobel Assembly at the Karolinska Institute described the discovery as "fundamentally important" for understanding how organisms develop and function. The Medicine or Physiology prize is the first in a series of Nobel announcements, running from October 7 to 14.
Ambros and Ruvkun first published their findings in 1993, unveiling a new layer of gene regulation that has since proven crucial and evolutionarily conserved. Dr. Claire Fletcher, a molecular oncology expert at Imperial College London, praised the discovery, stating that microRNA has transformed the way scientists approach treating diseases such as cancer by enabling precise regulation of gene function at the cellular level.
Each Nobel Prize comes with an award of 11 million Swedish crowns (approximately $1.1 million), which can be shared by up to three recipients. The next Nobel announcement, for Physics, is set for Tuesday, followed by Chemistry on Wednesday, Literature on Thursday, and the Nobel Peace Prize on Friday.
Democratic presidential candidate Kamala Harris campaigns in Michigan on Sunday while her Republican rival Donald Trump stops in three eastern battleground states just two days before elections
Democratic candidate Kamala Harris and Republican Donald Trump remain in a tight race in the country's seven battleground states
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
You can download the AnewZ application from Play Store and the App Store.